Access optionsAccess options
Subscribe to Journal
Get full journal access for 1 year
only $18.75 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Eeles, R.A. et al. Nat. Genet. 40, 316–321 (2008).
Pal, P. et al. Hum. Genet. 122, 251–259 (2007).
Lai, J. et al. Carcinogenesis 28, 1032–1039 (2007).
Cramer, S.D. et al. J. Natl. Cancer Inst. 95, 1044–1053 (2003).
Prorok, P.C. et al. Control. Clin. Trials 21, 273S–309S (2000).
Thomas, G. et al. Nat. Genet. 40, 310–315 (2008).
Borgono, C.A. et al. Mol. Cancer Res. 2, 257–280 (2004).
Woolf, S.H. N. Engl. J. Med. 333, 1401–1405 (1995).
de Koning, H.J. et al. Int. J. Cancer 98, 268–273 (2002).
Nam, R.K. et al. J. Clin. Oncol. 21, 2312–2319 (2003).
The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) is supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics and by contracts from the Division of Cancer Prevention, National Cancer Institute (NCI), US National Institutes of Health (NIH), Department of Health and Human Services (DHHS). The Health Professionals Follow-up Study (HPFS) study is supported by NIH grants CA55075 and U01CA098233. The American Cancer Society (ACS) study is supported by U01 CA098710. The Alpha Tocopherol Beta-Carotene Cancer Prevention (ATBC) Study is supported by the Intramural Research Program of the National Cancer Institute, NIH, and by US Public Health Service contracts N01-CN-45165, N01-RC-45035 and N01-RC-37004 from the National Cancer Institute, NIH, DHHS. A.S.K is supported by RO1CA112028. The genome-wide scans have been supported by the NCI, NIH, under contract N01-CO-12400. The content of this publication does not necessarily reflect the views or policies of the DHHS, nor does mention of trade names, commercial products or organizations imply endorsement by the US government.
Supplementary Figure 1, Supplementary Tables 1–6, Supplementary Methods (PDF 418 kb)
About this article
Multi-omics Biomarker Pipeline Reveals Elevated Levels of Protein-glutamine Gamma-glutamyltransferase 4 in Seminal Plasma of Prostate Cancer Patients
Molecular & Cellular Proteomics (2019)
Journal of Cellular Biochemistry (2019)
Nature Communications (2015)
Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial
The Prostate (2015)
Incorporating Known Genetic Variants Does Not Improve the Accuracy of PSA Testing to Identify High Risk Prostate Cancer on Biopsy
PLOS ONE (2015)